Rated a Top 10 free iPhone app by iMedicalApps
 
Oncology
Tumor Immunology, Immunotherapy, and Advances in Metastatic Melanoma
Table of Contents  |  CME Information  | Technical Requirements  | Login
  /2093/iPhoneAd/2093iPhoneAd.gif [NO]
Chapter 1
Immunology in Review
Chapter 2
Tumor-Fighting T-Cells
Chapter 3
Costimulation and the T-Cell Response
Chapter 4
Targeting Immune Stimulation: Clinical Application of CTLA-4 Blockade
Chapter 5
Autoimmune Effects of anti-CTLA-4 Antibodies: Management and Correlation with Benefit
Chapter 6
Targeting Mutated BRAF
Chapter 7
Emerging Agents and Strategies in the Treatment of Metastatic Melanoma



 
ACCME Disclaimer
 
Chapter 3 – Costimulation and the T-Cell Response

Editor-In-Chief
Jeffrey S. Weber Jeffrey S. Weber, MD, PhD
Senior Member, Moffitt Cancer Center
Director, Comprehensive Melanoma Research Center
Professor, Department of Oncologic Sciences
H. Lee Moffitt Cancer Center & Research Institute
Tampa, Florida
top

Activity Goal
The goal of this CME/CE activity is to support the learning of medical oncologists, dermatologists, primary care providers (internists and family practice practitioners) nurses/nurse practitioners, pharmacists, physician assistants, and other healthcare providers who require knowledge of the field of tumor immunology and those who manage patients with metastatic melanoma.

Target Audience
This CME/CE activity is designed for medical oncologists, dermatologists, primary care providers (internists and family practice practitioners) nurses/nurse practitioners, pharmacists, physician assistants, and other healthcare providers who require knowledge of the field of tumor immunology and those who manage patients with metastatic melanoma.
Learning Objective
Assess how secondary signals direct whether T-cells become activated, anergic, inhibited, or apoptotic in order to identify therapeutic targets for new immunotherapies in the treatment of cancer.

top
CME Information: Physicians
Statement of Accreditation
Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Projects In Knowledge® designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.



CE Information: Nurses
Projects In Knowledge® (PIK) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Projects In Knowledge is also an approved provider by the California Board of Registered Nursing, Provider Number CEP-15227.

Upon completion of this course, participants will be awarded 1.08 nursing contact hour(s).

DISCLAIMER: Accreditation refers to educational content only and does not imply ANCC, CBRN, or PIK endorsement of any commercial product or service.
top
Disclosure Information
 The Disclosure Policy of Projects In Knowledge requires that presenters comply with the Standards for Commercial Support. All faculty are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed in the course materials. For complete prescribing information on the products discussed during this CME/CE activity, please see your current Physicians' Desk Reference (PDR).

Jeffrey S. Weber, MD, PhD, is a consultant for Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd, and Pfizer, Inc.

Lauren A. Cerruto Medical Writer, has disclosed no significant relationships.

Peer Reviewer has disclosed no significant relationships.

Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no significant relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no significant relationships to disclose.

Projects In Knowledge’s staff members have no significant relationships to disclose.

top

Conflicts of interest are thoroughly vetted by the Executive Committee of Projects In Knowledge. All conflicts are resolved prior to the beginning of the activity by the Trust In Knowledge peer review process.

The opinions expressed in this activity are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided by Projects In Knowledge solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

Contract for Mutual Responsibility in CME/CE
Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

top 2093.03


Launch Activity
 
Projects In Knowledge®


Peer Reviewed
This independent CME/CE activity is supported by an educational grant from

Bristol-Myers Squibb.

Release Date: July 31, 2012.

Termination Date: July 30, 2013.

Estimated time for completion of this activity:
CME: 2.00 hours
CNE: 1.08 hours

CME/CE Instructions
To obtain CME/CE credit for this activity:
  1. Read the chapter carefully.
  2. Complete/submit the posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.
For questions about content or obtaining CME credit, please contact us.































 
 




ABOUT US  |  CONTACT US  |  CONTRACT  |  DIRECTIONS  |  PRIVACY POLICY  |  RESOURCES
Copyright © 1997-2013, Projects In Knowledge, Inc. All rights reserved.
PROJECTS IN KNOWLEDGE and LIVING MEDICAL ETEXTBOOK are registered trademarks of Projects In Knowledge, Inc.
PROJECTS IN KNOWLEDGE • 290 W. Mt. Pleasant Avenue, Suite 2350 • Livingston, New Jersey 07039 (973) 890-8988
false